32 search results
Primary tabs
- Cochrane Evidence (active tab)
- Resources
- Handbooks & Manuals
- Training & Workshops
- News
- All Cochrane sites
-
Cochrane EvidencePublished 7 Jun 2017
Exercise training before lung surgery in people with non-small cell lung cancer
Review question We reviewed the evidence about the effect of exercise training undertaken before lung surgery on the risk of developing a postoperative lung complication, the number of days needing a chest drain after surgery, length of hospital stay, fitness level, and lung function in patients with non-small cell lung cancer (NSCLC). Background Lung ... -
Cochrane EvidencePublished 21 Apr 2017
Surgery for limited-stage small-cell lung cancer
Background There are different types of lung cancer. One type is called small-cell lung cancer. Small-cell lung cancer is considered limited-stage if it is still within the chest or extensive-stage if it has spread outside the chest. Currently, chemotherapy and radiation therapy is recommended for treatment of limited-stage small-cell lung cancer if ... -
Cochrane EvidencePublished 11 Oct 2016
Postoperative radiotherapy for non-small cell lung cancer
Review question Do patients with non-small cell lung cancer live longer if they are given radiotherapy after surgery? Background Non-small cell lung cancer is the most common type of lung cancer. If the tumour is early stage, is not too big and has not spread to other parts of the body, doctors usually operate to remove it. Radiotherapy (treatment ... -
Cochrane EvidencePublished 25 May 2016
First-line treatment of advanced non-small cell lung cancer identified as being EGFR mutation positive
Background Lung cancer is the most common cancer in the world. As it shows few symptoms, it has often spread by the time it is diagnosed. Consequently surgery is usually not possible, and drug treatment, typically chemotherapy, is required. The most common type of lung cancer is non-small cell lung cancer (NSCLC). Around 10% to 15% of people with ... -
Cochrane EvidencePublished 20 Oct 2015
Comparing different types of chemotherapy for treatment of older people with advanced lung cancer
Background Worldwide, lung cancer is responsible for most cases of cancer-related death among individuals of both sexes. For adult patients with advanced disease, therapy regimens based on the combination of cisplatin or carboplatin with a different agent are considered the standard of care. However, few elderly patients have been included in relevant ... -
Cochrane EvidencePublished 25 Sep 2015
Non-invasive positive pressure ventilation for prevention of complications after pulmonary resection in lung cancer patients
Review question: Is the use of non-invasive positive pressure ventilation (NIPPV) safe and effective to prevent complications in the postoperative period in patients who underwent pulmonary resection for lung cancer? Background: Death after lung cancer resection is usually caused by complications, particularly pulmonary complications, during the postoperative ... -
Cochrane EvidencePublished 2 Aug 2015
A comparison of platinum-based and non-platinum-based chemotherapy regimens for the treatment of small cell lung cancer
Review question Do patients with small cell lung cancer (SCLC) who receive platinum-based chemotherapy treatment live longer than those who receive non-platinum-based chemotherapy treatment? Other questions include: do these patients also respond better to treatment, experience fewer side-effects and have a better quality of life? Background SCLC ... -
Cochrane EvidencePublished 2 Mar 2015
Chemotherapy after surgery for early stage non-small cell lung cancer
Review question Do patients with non-small cell lung cancer live longer if they are given chemotherapy after surgery? Background Non-small cell lung cancer is the most common type of lung cancer. If the tumour is early stage, not too big and has not spread to other parts of the body, doctors usually operate to remove it. At the same time, they ... -
Cochrane EvidencePublished 14 Jan 2015
Comparing the effect of different courses of radiotherapy to the chest for patients with incurable lung cancer
Review Question What is the best way to give radiotherapy to patients with incurable lung cancer. What doses give the best balance between symptom control and side effects? Does giving more radiotherapy improve the chance of a patient being alive in one or two years? Background In most developed countries lung cancer is one of the commonest tumours. ... -
Cochrane EvidencePublished 17 Nov 2014
Cetuximab: a new treatment for advanced non-small cell lung cancer
Lung cancer is the most common cancer in the world. Advanced non-small cell lung cancer (NSCLC) accounts for about 60% of all lung cancer cases. Since the effectiveness of current standard treatment for advanced NSCLC (i.e. chemotherapy) has reached a ceiling, there is a continuous need for new, more effective treatments to further improve the outcome ...
